United Therapeutics Corporation Reports Third Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
United Therapeutics (UTHR) Tops Q3 EPS by 1.10, Revenues Beat
October 28, 2020 6:16 AM EDTUnited Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $3.88, $1.10 better than the analyst estimate of $2.78. Revenue for the quarter came in at $380.1 million versus the consensus estimate of $356.95 million.
"As our core business continues to perform well, we have a solid footing to enter 2021... More
